Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19)

NCT04318444 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped The Institutional Review Board closed the study

Conditions

COVID-19
Corona Virus Infection

Interventions

DRUG: Hydroxychloroquine
DRUG: Placebo oral tablet

Sponsor

Columbia University